查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439280

无针注射-全球市场考量、竞争格局、市场预测（2030）

Needle Free Injections - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球无针注射系统市场规模预计2023年将达到124.9亿美元，2030年将达到276.5亿美元，2024-2030年预测期间复合年增长率为14.16%。由于慢性病盛行率上升、针刺伤普遍存在、自我注射器需求增加、疫苗接种计画增加以及产品开发中的技术创新等因素，无针注射系统的需求呈现成长趋势。

无针注射市场动态

无针注射技术包括结合不同模式并利用压力进行皮下给药的药物输送系统，因此无需皮下注射针。

影响无针注射市场成长的主要因素之一是患者和照护者中针刺伤的数量不断增加。根据世界卫生组织（WHO）（2019）提供的数据，全球每年有 3,500 万名医护人员遭受超过 200 万次职业针刺伤害。

根据美国疾病管制与预防中心 (CDC) 和欧盟职业安全与健康管理局 2019 年的报告，美国和欧洲医院医护人员的针刺伤病例超过 385,000 例，每年超过 100 万例， 分别。

针刺伤会增加 20 多种血液传染感染的风险，包括 HIV、C型肝炎和B型肝炎。除了传播血源性病原体外，针刺伤还会导致慢性疾病，还会产生心理影响。此外，处理针刺和尖锐伤口的成本很高。因此，由于上述因素，市场对无针注射系统的需求不断增加，这种系统不仅可以改善医疗保健提供者、护理人员和患者的安全前景，而且还可以安全地进行药物和治疗。

此外，糖尿病等慢性病盛行率的上升也是促进无针注射市场成长的主要因素之一。

根据IDF Diabetes Atlas（2023 年）的统计，2021 年有 5.37 亿成年人患有糖尿病。预计到 2030 年，这一数字将增至 6.43 亿，到 2045 年将增至 7.83 亿。糖尿病患者需要定期服用胰岛素作为主要治疗方法之一。许多醣尿病患者每天需要多次剂量的胰岛素，并且经常经历与注射相关的焦虑和疼痛。无针注射提供了一种几乎无痛的方式来准确地自我注射胰岛素，从而提高患者对治疗的依从性和依从性。

此外，对大部分人口提供 COVID-19 疫苗的高度关注也导致对无针注射器的需求增加。

因此，慢性病盛行率的上升、针刺伤害的增加以及对更安全的自我注射器的需求不断增长预计将推动无针注射市场的成长。

然而，对培训和设备维护的更高要求、给药途径的限制以及设计尺寸变化的限制可能是无针注射市场成长的某些限制因素。

无针注射细分市场分析

在无针注射器市场的应用领域，用于胰岛素输送的无针注射器预计将在预测期内占据重要份额。这是由于全世界糖尿病盛行率不断上升。

糖尿病患者每天需要多次服用胰岛素，但使用传统注射器和针头注射胰岛素对患者来说可能是一项艰鉅的任务。这些装置有助于透过喷嘴孔轻鬆注射胰岛素，从而产生细小的胰岛素流。这种水流很容易穿透皮肤。

本报告提供了全球无针注射市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第一章 无针注射市场报告简介

第二章无针注射市场概要

  • 调查范围
  • 市场概况
  • 竞争评估

第三章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章 无针注射市场主要因素分析

  • 无针注射市场的驱动因素
    • 慢性病患病率上升
    • 针刺伤增加
    • 更重视疫苗接种计划
    • 产品开发创新
  • 市场限制与挑战
    • 设备维护成本高、训练要求高
    • 产品设计限制
  • 市场机会
    • 加强产品设计
    • 推出针对新兴市场的产品

第五章无针注射市场波特五力分析

第六章 无针注射市场布局

  • 按产品类型
    • 填充模具
    • 预先填充
  • 按技术
    • 喷射式
    • 弹簧式
    • 其他
  • 使用性别
    • 可重复使用的
    • 一次性的
  • 按用途
    • 疫苗接种
    • 胰岛素
    • 皮肤科
  • 按最终用户
    • 医院
    • 诊所
    • 居家护理环境
  • 按地区
    • 北美无针注射市场规模（2021-2030）
    • 欧洲无针注射市场规模（2021-2030）
    • 亚太地区无针注射市场规模（2021-2030）
    • 其他地区无针注射市场规模（2021-2030年）

第七章 无针注射市场公司及产品概况

  • IntegriMedical LLC
  • INJEX Pharma GmbH
  • PharmaJet
  • CrossJect
  • European Pharma Group BV
  • National Medical Products Inc
  • Akra DermaJet
  • Meika Medical CO.
  • Basco India
  • Mystic Pharmaceuticals Inc
  • Technologies Medicales Internationales (MIT Canada) Inc.
  • INOVIO Pharmaceuticals
  • MADA MEDICAL PRODUCTS INC
  • Portal Instruments
  • D'Antonio Consultants International, Inc

第8章 KOL观点

第9章 专案方法

第10章 DelveInsight服务内容

第 11 章关于 DelveInsight

第十二章 免责声明与联络我们

Product Code: DIMDCL0070

Needle-Free Injections Market By Product Type (Fillable and Prefilled), Technology (Jet-Based, Spring-Based, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to the increased risk of communicable infections as a result of needle injuries and needle phobia among the population.

The global needle-free injection systems market was valued at USD 12.49 billion in 2023, growing at a CAGR of 14.16% during the forecast period from 2024 to 2030 to reach USD 27.65 billion by 2030. The demand for needle-free injection systems is witnessing growth due to the rising prevalence of chronic diseases, expanding number of needle-stick injuries, increasing requirement of self-injection devices, growing number of vaccination programs, and technological innovation in product development, among other factors.

Needle-Free Injections Market Dynamics:

Needle-free injection technology encompasses a wide spectrum of drug delivery systems that help in the administration of drugs through the skin using pressure combining different modes, pushing the drug through the skin, thereby eliminating the need for a hypodermic needle.

One of the major factors influencing the growth of the needle-free injection market is the rising number of needle stick injuries among patients and caregivers. As per the data provided by the World Health Organization (2019), globally more than two million occupational exposures to sharp injuries occur among 35 million healthcare workers annually.

According to the Centers for Disease Control and Prevention (CDC) and European Agency for Safety and Health at Work (EU-Occupation Safety and Health Administration) reports published in 2019, there are more than 385,000 and 1,000,000 needle stick injury cases annually among hospital healthcare workers in the United States and Europe, respectively.

Needle-stick injuries increase the risk of more than 20 types of blood-borne infectious diseases which include HIV, hepatitis C, and hepatitis B. In addition to becoming infected with blood-borne pathogens, needle stick injuries may result in chronic diseases and also cause psychological effects. Furthermore, the management of needle sticks and sharp injuries can be cost-intensive. Therefore, owing to the abovementioned factors, there is a growing need for needle-free injection systems in the market which allow for the safe administration of drugs and therapeutics as well improve the safety prospects of healthcare providers, caregivers, and patients.

Moreover, the rising prevalence of chronic diseases, such as diabetes is also one of the major factors aiding in the needle-free injections market growth.

As per statistics by the IDF Diabetes Atlas (2023), 537 million adults were living with diabetes in 2021. This number is predicted to rise to 643 million by 2030 and 783 million by 2045. People suffering from diabetes require regular administration of insulin as one of their key treatment regimens. Many diabetes patients require multiple daily doses of insulin and often experience anxiety and pain associated with injections. Needle-free injections offer a virtually painless method for the administration of insulin by themselves in a precise manner and thereby improving the adherence to treatment and compliance by patients.

Moreover, the increased focus on providing COVID-19 vaccines to the majority of the population has also resulted in the increased demand for needle-free injection devices as many pharmaceutical companies are entering into partnerships with needle-free injection manufacturers for expanding their customer reach.

Therefore, the rising prevalence of chronic diseases, and the increasing number of needle stick injuries, coupled with the growing demand for safer self-injection devices are projected to drive the needle-free injections market growth.

However, higher requirements for training and device maintenance, limitations in the route of administration, and limitations in the variation in the design size may prove to be certain restraints to the needle-free injection market growth.

Needle-Free Injections Market Segment Analysis:

Needle-Free Injections market by Product Type (Fillable and Prefilled), Technology (Jet-Based, Spring-Based, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the application segment of the needle-free injections market, insulin delivery needle-free injections are expected to account for a significant share of the market during the forecast period. This can be attributed to the rising prevalence of diabetic population across the globe.

Diabetic patients require multiple doses of insulin in a day, which can be a daunting process for patients in case of using conventional syringes and needles for insulin administration. These devices aid in the easy administration of insulin through the nozzle orifice, which results in the generation of a fine stream of insulin. This stream then easily penetrates the skin.

Needle-free insulin injection systems offer the least resistant path for insulin administration, thereby facilitating the even spreading of the insulin in the subcutaneous layer.

Therefore, Needle-free injection devices for insulin administration are gaining popularity and are more extensively used than for other applications owing to the above-stated reason.

North America is expected to dominate the Overall Needle-Free Injections Market:

Among all the regions, North America is expected to account for the largest share of the needle-free injection market. The growing number of chronic diseases, more focus on vaccination programs, and access to better healthcare infrastructure along with the presence of major market players in the region are predicted to be the major influencing factors in driving the overall growth of the needle-free injections market over the forecast period.

As per the data published by National Center for Immunization and Respiratory Diseases (NCIRD) under the Centers for Disease Control and Prevention 2022, influenza was associated with 9 million illnesses, 4 million medical visits, and about 10,000 hospitalizations in the United States between 2021 and 2022.

Needle-free injection systems are used in the administration of different vaccines including influenza vaccines. CDC works each year to increase the number of people who receive a flu vaccine and eliminate barriers to vaccination. As flu vaccines are commonly administered in pediatric patients, these systems help in the easy administration of vaccines to children and people suffering from needle phobia, and other apprehensions. One example of this is the PharmaJet Stratis Needle-Free Injector which is the first needleless intramuscular Jet Injector approved by the US Food and Drug Administration for the delivery of an influenza vaccine.

Moreover, the well-established healthcare infrastructure in the country which can be supported by the high per capita healthcare expenditure in the country as well as the presence of a highly aware patient population further encourages people to opt for such devices.

Therefore, the above-mentioned factors are expected to propel the growth of the North America Needle-free injections market.

Needle-Free Injections Market Key Players:

Some of the key market players operating in the needle-free injection systems market include IntegriMedical LLC, INJEX Pharma GmbH, PharmaJet Corporation, CrossJect, European Pharma Group BV, National Medical Products Inc, Akra DermaJet, Meika Medical Co, Basco India., Mystic Pharmaceuticals Inc, Technologies Medicales Internationales (MIT Canada) Inc., INOVIO Pharmaceuticals, MADA MEDICAL PRODUCTS INC., Portal Instruments, D'Antonio Consultants International, Inc and others.

Recent Developmental Activities in Needle-Free Injections Market:

In August 2022, PharmaJet and their partner Zydus Cadila announced the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D the world's first Plasmid DNA Vaccine for COVID-19. The vaccine- ZyCoV-D is exclusively administered by the deployment of the PharmaJet Tropis® Needle-free Injection System.

Key Takeaways from the Needle-Free Injections Market Report Study

Market size analysis for current needle-free injections market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global needle-free injections market

Various opportunities available for the other competitor in the needle-free injections market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current needle-free injections market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for needle-free injection market growth in the coming future?

Target Audience who can be benefited from this Needle-Free Injections Market Report Study

Needle-free injection systems products providers

Research organizations and consulting companies

Needle-free injection systems -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in needle-free injections market

Various End-Users who want to know more about the needle-free injections market and the latest technological developments in the needle-free injections market

Frequently Asked Questions for Needle-Free Injections Market:

1. What is a Needle Free Injection System?

Needle-free injection technology encompasses a wide spectrum of technology that includes a wide variety of drug delivery systems that help in the administration of drugs through the skin using pressure combining different modes, pushing the drug through the skin, thereby eliminating the need for a hypodermic needle.

2. What is the market for global needle-free injections?

The global needle-free injection systems market was valued at USD 12.49 billion in 2023, growing at a CAGR of 14.16% during the forecast period from 2024 to 2030 to reach USD 27.65 billion by 2030.

3. What are the drivers for the global needle-free injections market?

The major drivers of the global needle-free injections market growth are the rising prevalence of chronic diseases, an increasing number of needle stack and sharp injuries, and a rising number of trauma cases, among other factors.

4. Who are the key players operating in the global needle-free injections market?

Some of the key market players operating in the needle-free injection systems market include IntegriMedical LLC, INJEX Pharma GmbH, PharmaJet Corporation, CrossJect, European Pharma Group BV, National Medical Products Inc, Akra DermaJet, Meika Medical Co, Basco India., Mystic Pharmaceuticals Inc, Technologies Medicales Internationales (MIT Canada) Inc., INOVIO Pharmaceuticals, MADA MEDICAL PRODUCTS INC., Portal Instruments, D'Antonio Consultants International, Inc and others.

5. Which region has the highest share in the needle-free injections market?

North America is expected to dominate the overall needle-free injections market during the forecast period, 2024 to 2030. The accumulation of the highest revenue in the market can be ascribed to the rising prevalence of chronic diseases, increased focus on vaccination programs, improving the safety of healthcare providers, and increasing collaborations between key market players in the region.

Table of Contents

1. Needle-Free Injections Market Report Introduction

2. Needle-Free Injections Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Needle-Free Injections Market Key Factors Analysis

  • 4.1. Needle-Free Injections Market Drivers
    • 4.1.1. Rising Prevalence of Chronic Diseases
    • 4.1.2. Rising Number of Needle Stick Injuries
    • 4.1.3. Growing Focus on Vaccination Programs
    • 4.1.4. Technological Innovation in Product Development
  • 4.2. Market Restraints and Challenges
    • 4.2.1. High Device Maintenance and Requirement of Training
    • 4.2.2. Limitation with Product Design
  • 4.3. Market Opportunities
    • 4.3.1. Enhancing Product Design
    • 4.3.2. Targeting Emerging Markets for Product Launches

5. Needle-Free Injections Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Needle-Free Injections Market Layout

  • 6.1. By Product Type
    • 6.1.1. Fillable
    • 6.1.2. Prefilled
  • 6.2. By Technology
    • 6.2.1. Jet-Based
    • 6.2.2. Spring-Based
    • 6.2.3. Others
  • 6.3. By Usability
    • 6.3.1. Reusable
    • 6.3.2. Disposable
  • 6.4. By Application
    • 6.4.1. Vaccine
    • 6.4.2. Insulin
    • 6.4.3. Dermatology
    • 6.4.4. Others
  • 6.5. By End-User
    • 6.5.1. Hospitals
    • 6.5.2. Clinics
    • 6.5.3. Homecare Settings
    • 6.5.4. Others
  • 6.6. By Geography
    • 6.6.1. North America Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.1.1. United States Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.1.2. Canada Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.1.3. Mexico Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.2. Europe Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.2.1. France Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.2.2. Germany Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.2.3. United Kingdom Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.2.4. Italy Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.2.5. Spain Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.2.6. Rest of Europe Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.3. Asia-Pacific Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.3.1. China Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.3.2. Japan Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.3.3. India Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.3.4. Australia Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.3.5. South Korea Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.3.6. Rest of Asia-Pacific Needle-Free Injections Market Size in USD million (2021-2030)
    • 6.6.4. Rest of the World (RoW) Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.4.1. Middle East Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.4.2. Africa Needle-Free Injections Market Size in USD million (2021-2030)
      • 6.6.4.3. South America Needle-Free Injections Market Size in USD million (2021-2030)

7. Needle-Free Injections Market Company and Product Profiles

  • 7.1. IntegriMedical LLC
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. INJEX Pharma GmbH
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. PharmaJet
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. CrossJect
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. European Pharma Group BV
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. National Medical Products Inc
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Akra DermaJet
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Meika Medical CO.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Basco India
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Mystic Pharmaceuticals Inc
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Technologies Medicales Internationales (MIT Canada) Inc.
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. INOVIO Pharmaceuticals
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. MADA MEDICAL PRODUCTS INC
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Portal Instruments
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. D'Antonio Consultants International, Inc
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Needle-Free Injections Market in Global (2021-2030)
  • Table 3: Needle-Free Injections Market in Global by Product Type (2021-2030)
  • Table 4: Needle-Free Injections Market in Global by Technology (2021-2030)
  • Table 5: Needle-Free Injections Market in Global by Usability (2021-2030)
  • Table 6: Needle-Free Injections Market in Global by Application (2021-2030)
  • Table 7: Needle-Free Injections Market in Global by End-User (2021-2030)
  • Table 8: Needle-Free Injections Market in Global by Geography (2021-2030)
  • Table 9: Needle-Free Injections Market in North America (2021-2030)
  • Table 10: Needle-Free Injections Market in the US (2021-2030)
  • Table 11: Needle-Free Injections Market in Canada (2021-2030)
  • Table 12: Needle-Free Injections Market in Mexico (2021-2030)
  • Table 13: Needle-Free Injections Market in Europe (2021-2030)
  • Table 14: Needle-Free Injections Market in France (2021-2030)
  • Table 15: Needle-Free Injections Market in Germany (2021-2030)
  • Table 16: Needle-Free Injections Market in the United Kingdom (2021-2030)
  • Table 17: Needle-Free Injections Market in Italy (2021-2030)
  • Table 18: Needle-Free Injections Market in Spain (2021-2030)
  • Table 19: Needle-Free Injections Market in Rest of Europe (2021-2030)
  • Table 20: Needle-Free Injections Market in Asia-Pacific (2021-2030)
  • Table 21: Needle-Free Injections Market in China (2021-2030)
  • Table 22: Needle-Free Injections Market in Japan (2021-2030)
  • Table 23: Needle-Free Injections Market in India (2021-2030)
  • Table 24: Needle-Free Injections Market in Australia (2021-2030)
  • Table 25: Needle-Free Injections Market in South Korea (2021-2030)
  • Table 26: Needle-Free Injections Market in Rest of Asia-Pacific (2021-2030)
  • Table 27: Needle-Free Injections Market in the Rest of the World (2021-2030)
  • Table 28: Needle-Free Injections Market in the Middle East (2021-2030)
  • Table 29: Needle-Free Injections Market in Africa (2021-2030)
  • Table 30: Needle-Free Injections Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Needle-Free Injections Market in Global (2021-2030)
  • Figure 3: Needle-Free Injections Market in Global by Product Type (2021-2030)
  • Figure 4: Needle-Free Injections Market in Global by Technology (2021-2030)
  • Figure 5: Needle-Free Injections Market in Global by Usability (2021-2030)
  • Figure 6: Needle-Free Injections Market in Global by Application (2021-2030)
  • Figure 7: Needle-Free Injections Market in Global by End-User (2021-2030)
  • Figure 8: Needle-Free Injections Market in Global by Geography (2021-2030)
  • Figure 9: Needle-Free Injections Market in North America (2021-2030)
  • Figure 10: Needle-Free Injections Market in the US (2021-2030)
  • Figure 11: Needle-Free Injections Market in Canada (2021-2030)
  • Figure 12: Needle-Free Injections Market in Mexico (2021-2030)
  • Figure 13: Needle-Free Injections Market in Europe (2021-2030)
  • Figure 14: Needle-Free Injections Market in France (2021-2030)
  • Figure 15: Needle-Free Injections Market in Germany (2021-2030)
  • Figure 16: Needle-Free Injections Market in the United Kingdom (2021-2030)
  • Figure 17: Needle-Free Injections Market in Italy (2021-2030)
  • Figure 18: Needle-Free Injections Market in Spain (2021-2030)
  • Figure 19: Needle-Free Injections Market in Rest of Europe (2021-2030)
  • Figure 20: Needle-Free Injections Market in Asia-Pacific (2021-2030)
  • Figure 21: Needle-Free Injections Market in China (2021-2030)
  • Figure 22: Needle-Free Injections Market in Japan (2021-2030)
  • Figure 23: Needle-Free Injections Market in India (2021-2030)
  • Figure 24: Needle-Free Injections Market in Australia (2021-2030)
  • Figure 25: Needle-Free Injections Market in South Korea (2021-2030)
  • Figure 26: Needle-Free Injections Market in Rest of Asia-Pacific (2021-2030)
  • Figure 27: Needle-Free Injections Market in the Rest of the World (2021-2030)
  • Figure 28: Needle-Free Injections Market in the Middle East (2021-2030)
  • Figure 29: Needle-Free Injections Market in Africa (2021-2030)
  • Figure 30: Needle-Free Injections Market in South America (2021-2030)
  • Figure 31: Market Drivers
  • Figure 32: Market Barriers
  • Figure 33: Marker Opportunities
  • Figure 34: PORTER'S Five Force Analysis